Category: Life Stories
Lincoln’s Take Steps Walk: A Community Coming Together for IBD Hope
Lincoln’s recent Take Steps walk brought the community together to support IBD research and awareness. Beyond fundraising, these events provide crucial resources and community connection for people with Crohn’s disease and ulcerative colitis.
New Stem Cell Research Could Change Surgery Outlook for Crohn’s
New research into mesenchymal stem cell therapy for Crohn’s disease shows promise in reducing the need for repeat surgeries by actually healing damaged tissue rather than just managing symptoms. This regenerative approach could represent a fundamental shift from reactive treatment to true healing for many IBD patients.
New IBD Pregnancy Guidelines Offer Hope for Future Mothers
New global guidelines provide evidence-based recommendations for women with IBD considering pregnancy, offering hope and clear guidance for family planning. Most IBD medications are considered safe during pregnancy, and staying in remission is key to healthy outcomes.
When Matcha Becomes a Risk: IBD Safety Considerations
A young woman’s hospitalization after regular matcha consumption highlights important safety considerations for IBD patients. Understanding the concentrated nature of matcha and quality concerns can help us make informed decisions about incorporating this popular beverage into our routines.
Could Breastmilk Hold the Key to Gentler IBD Treatment?
New research explores how antibodies found in breastmilk could lead to gentler IBD treatments that work with the body’s natural healing mechanisms. This approach could offer hope for managing inflammation without the harsh side effects of current therapies.
New Immune Discovery Could Transform Crohn’s Treatment Forever
Researchers have identified specific molecules that turn gut immune cells into troublemakers in Crohn’s disease. This breakthrough could lead to precision treatments that target only problematic immune pathways while preserving overall immune function.
New Single-Cell Research Offers Fresh Hope for Better Crohn’s Treatments
New single-cell research is revealing which specific immune cells drive Crohn’s inflammation, potentially leading to more precise treatments with fewer side effects. This breakthrough could transform how we approach IBD therapy by targeting only problematic cells while preserving helpful immune function.
Exercise with Crohn’s: Finding Your Path to Gentle Movement
Exercise with Crohn’s doesn’t have to look like anyone else’s routine—it just has to work for you. Gentle, consistent movement can reduce stress and improve quality of life, but the key is finding activities that feel supportive rather than demanding.
$420M Partnership Brings New Hope for Better IBD Treatments
A new $420 million partnership between Genentech and OMass Therapeutics is developing innovative oral IBD treatments using groundbreaking protein research technology. This collaboration represents significant hope for better treatment options that could transform daily life for millions living with Crohn’s disease and ulcerative colitis.
New Hope: Guselkumab Brings Targeted Relief to IBD Patients
Guselkumab, a new biologic therapy targeting IL-23, is showing remarkable promise for IBD patients with over half of Crohn’s patients achieving remission at 12 weeks. This precision approach to inflammation represents a significant advancement in treatment options for those struggling with conventional therapies.
